— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.7% 1M: -18.2% 3M: +13.9% YTD: +46.9% 1Y: +210.4% 3Y: -21.3% 5Y: -59.5%
$13.07
-0.38 (-2.83%)
 
Weekly Expected Move ±6.5%
$11 $12 $13 $14 $15
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $1.1B mcap · 79M float · 5.95% daily turnover · Short 56% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$320M -22.3% ▼
Net Income
-$314M -26.9% ▼
EPS (Diluted)
$-3.38 -10.1% ▼
EBITDA
-$302M -19.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$5M$0$0$0$0
Gross Profit-$5M$0$0$0$0
Gross Margin—————
R&D Expenses$81M$127M$175M$189M$221M
SG&A Expenses$36M$0$0$0$99M
Operating Expenses$117M$177M$235M$262M$320M
Operating Income-$121M-$177M-$235M-$262M-$320M
Operating Margin—————
Interest Expense$2M$4M$7M$8M$9M
Income Before Tax-$121M-$174M-$215M-$247M-$314M
Tax Expense-$3M$288K$408K$468K-$551K
Net Income-$118M-$174M-$216M-$247M-$314M
Net Margin—————
EPS (Diluted)$-2.26$-2.99$-3.24$-3.07$-3.38
EBITDA-$114M-$172M-$228M-$254M-$302M
Shares Outstanding52M58M67M81M93M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms